Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/3/26 12:10 | 3/2/26 | VIR | Health | BioPrd | Biological Products, (No Diag | Sato Vicki L | CA | D | 5 | S.d | -986 | 6.54 | 0 | -151 | 1,166 | D | ||||||||||||||||
2/26/26 16:56 | 2/24/26 | VIR | Health | BioPrd | Biological Products, (No Diag | Sabatini Brent | CA | O | SVP, Chi | 3 | S.d | -39 | 8.18 | 0 | -5 | 71 | D | |||||||||||||||
2/26/26 16:55 | 2/24/26 | VIR | Health | BioPrd | Biological Products, (No Diag | O'Byrne Jason | CA | O | EVP,CFO | 2 | S.d | -31 | 8.37 | 0 | -4 | 164 | D | |||||||||||||||
2/26/26 16:55 | 2/24/26 | VIR | Health | BioPrd | Biological Products, (No Diag | Eisner Mark | CA | O | EVP,Chie | 2 | S.dm | -50 | 8.85 | 0 | -6 | 158 | D | |||||||||||||||
2/26/26 16:54 | 2/24/26 | VIR | Health | BioPrd | Biological Products, (No Diag | De Verneuil Vanina | CA | O | EVP,GC,C | 2 | S.dm | -197 | 9.28 | 0 | -21 | 130 | D | |||||||||||||||
2/26/26 16:54 | 2/24/26 | VIR | Health | BioPrd | Biological Products, (No Diag | De Backer Marianne | CA | DO | CEO | 2 | S.d | -283 | 8.36 | 0 | -34 | 1,089 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |